1 | VSIG4
|
| VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism.
|
| Li J, Diao B, Guo S, Huang X, Yang C, Feng Z, Yan W, Ning Q, Zheng L, Chen Y, Wu Y.
|
| Nat Commun 8(1):1322. doi: 10.1038/s41467-017-01327-4.
2017
|
2 | VSIG4
|
| The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
|
| Roh J, Jeon Y, Lee AN, Lee SM, Kim Y, Sung CO, Park CJ, Hong JY, Yoon DH, Suh C, Huh J, Choi I, Park CS.
|
| Oncotarget 8(35):58122-58132. doi: 10.18632/oncotarget.19468. eCollection 2017 Aug 29.
2017
|
3 | VSIG4
|
| The Significance of VSIG4 Expression in Ovarian Cancer.
|
| Byun JM, Jeong DH, Choi IH, Lee DS, Kang MS, Jung KO, Jeon YK, Kim YN, Jung EJ, Lee KB, Sung MS, Kim KT.
|
| Int J Gynecol Cancer 27(5):872-878. doi: 10.1097/IGC.0000000000000979.
2017
|
4 | VSIG4
|
| Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivity.
|
| Wen Y, Ouyang Z, Schoonooghe S, Luo S, De Baetselier P, Lu W, Muyldermans S, Raes G, Zheng F.
|
| Immunobiology 222(6):807-813. doi: 10.1016/j.imbio.2016.11.008. Epub 2016 Nov 18.
2017
|
5 | VSIG4
|
| CRIg Functions as a Macrophage Pattern Recognition Receptor to Directly Bind and Capture Blood-Borne Gram-Positive Bacteria.
|
| Zeng Z, Surewaard BG, Wong CH, Geoghegan JA, Jenne CN, Kubes P.
|
| Cell Host Microbe 20(1):99-106. doi: 10.1016/j.chom.2016.06.002. Epub 2016 Jun 23.
2016
|
6 | VSIG4
|
| Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response.
|
| Jung K, Seo SK, Choi I.
|
| Immunol Lett 165(2):78-83. doi: 10.1016/j.imlet.2015.04.004. Epub 2015 Apr 27.
2015
|
7 | ITGAM, PRKCA, VSIG4
|
| Protein kinase cα regulates the expression of complement receptor Ig in human monocyte-derived macrophages.
|
| Ma Y, Usuwanthim K, Munawara U, Quach A, Gorgani NN, Abbott CA, Hii CS, Ferrante A.
|
| J Immunol 194(6):2855-61. doi: 10.4049/jimmunol.1303477. Epub 2015 Feb 16.
2015
|
8 | VSIG4
|
| VSIG4 expression on macrophages facilitates lung cancer development.
|
| Liao Y, Guo S, Chen Y, Cao D, Xu H, Yang C, Fei L, Ni B, Ruan Z.
|
| Lab Invest 94(7):706-15. doi: 10.1038/labinvest.2014.73. Epub 2014 May 26.
2014
|
9 | CLIC3, VSIG4
|
| CRIg signals induce anti-intracellular bacterial phagosome activity in a chloride intracellular channel 3-dependent manner.
|
| Kim KH, Choi BK, Song KM, Cha KW, Kim YH, Lee H, Han IS, Kwon BS.
|
| Eur J Immunol 43(3):667-78. doi: 10.1002/eji.201242997. Epub 2013 Jan 31.
2013
|
10 | VSIG4
|
| Phenotypic and functional profiles of CRIg (Z39Ig)-expressing macrophages in the large intestine.
|
| Tanaka M, Nagai T, Usami M, Hasui K, Takao S, Matsuyama T.
|
| Innate Immun 18(2):258-67. doi: 10.1177/1753425911400641. Epub 2011 Jul 18.
2012
|
11 | VSIG4
|
| Down-regulation of Z39Ig on macrophages by IFN-gamma in patients with chronic HBV infection.
|
| Guo S, Yang C, Mei F, Wu S, Luo N, Fei L, Chen Y, Wu Y.
|
| Clin Immunol 136(2):282-91. doi: 10.1016/j.clim.2010.03.007. Epub 2010 Apr 15.
2010
|
12 | VSIG4
|
| Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
|
| Wiesmann C, Katschke KJ, Yin J, Helmy KY, Steffek M, Fairbrother WJ, McCallum SA, Embuscado L, DeForge L, Hass PE, van Lookeren Campagne M.
|
| Nature 444(7116):217-20. Epub 2006 Oct 15.
2006
|
13 | VSIG4
|
| VSIG4, a B7 family-related protein, is a negative regulator of T cell activation.
|
| Vogt L, Schmitz N, Kurrer MO, Bauer M, Hinton HI, Behnke S, Gatto D, Sebbel P, Beerli RR, Sonderegger I, Kopf M, Saudan P, Bachmann MF.
|
| J Clin Invest 116(10):2817-26.
2006
|
14 | VSIG4
|
| CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens.
|
| Helmy KY, Katschke KJ Jr, Gorgani NN, Kljavin NM, Elliott JM, Diehl L, Scales SJ, Ghilardi N, van Lookeren Campagne M.
|
| Cell 124(5):915-27.
2006
|
15 | VSIG4
|
| Cloning of Z39Ig, a novel gene with immunoglobulin-like domains located on human chromosome X.
|
| Langnaese K, Colleaux L, Kloos DU, Fontes M, Wieacker P.
|
| Biochim Biophys Acta 1492(2-3):522-5. 2000
|